Release Date:  December 11, 2001

NOTICE:  NOT-CA-02-005

National Cancer Institute

The NATIONAL CANCER INSTITUTE is requesting applications for the following 
initiative:  Rapid Access to Intervention Development (RAID).  RAID will make 
available to academic investigators, on a competitive basis, the preclinical 
development contract resources of NCI's Developmental Therapeutics Program.  
RAID is not a grant program to originating investigators.  The goal of RAID is 
the rapid movement of novel molecules and concepts from the laboratory to the 
clinic for proof-of-principle clinical trials, using NCI's contract research 
mechanisms.  RAID will assist investigators who submit successful applications 
by providing any (or all) of the preclinical development steps that may be 
obstacles to clinical translation.  These may include, for example, production, 
bulk supply, GMP manufacturing, formulation and toxicology.  Suitable agents for 
RAID will include small molecules, biologics or vaccines.

There are two receipt dates for requests for RAID support per year, February 1 
and August 1.  Current requests must be received by February 1, 2002, with all 
materials submitted directly to the office listed below.

LONGER BE ACCEPTED.  This policy does not apply to courier deliveries (i.e. 
FEDEX, UPS, DHL, etc.) 
(https://grants.nih.gov/grants/guide/notice-files/NOT-CA-02-002.html).  This 
change in practice is effective immediately.  This policy is similar to and 
consistent with the policy for applications addressed to Centers for Scientific 
Review as published in the NIH Guide Notice 

For information on process and procedure of requests for RAID resources, visit 
the DTP web site http://dtp.nci.nih.gov/.  Inquiries are encouraged, the 
opportunity to clarify issues or questions is welcome.  Academic investigators 
may have collaborations with small-business partners and still qualify for RAID 
funding.  Non-profit organizations other than universities may also submit RAID 
applications.  Please note that a maximum of two distinct requests for support 
per investigator can be submitted for each receipt date.  Please contact:


Office of Associate Director
Developmental Therapeutics Program
National Cancer Institute
Executive Plaza North Building, Suite 8022
6130 Executive Blvd.
Rockville, MD  20852
Tel:  (301) 496-8720
Fax:  (301) 402-0831

Return to Volume Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.